Pharmaceuticals Stocks
169 acciones seguidas en Pharmaceuticals
| Ticker | Empresa | Cap. de mercado | P/E | Señales |
|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. - Common Stock | $95.1M | — | — |
| ACB | Aurora Cannabis Inc. - Common Shares | $327.2M | — | — |
| ACRS | Aclaris Therapeutics, Inc. - Common Stock | $866.3M | — | — |
| ADIL | Adial Pharmaceuticals, Inc - Common Stock | $2.1M | — | — |
| ADXN | Addex Therapeutics Ltd - American Depositary Shares | $8.1M | — | — |
| AKAN | Akanda Corp. - Common Shares | $333K | — | — |
| ALMS | Alumis Inc. - Common Stock | $2.9B | — | — |
| AMLX | Amylyx Pharmaceuticals, Inc. - Common Stock | $2.4B | — | — |
| AMPH | Amphastar Pharmaceuticals, Inc. - Common Stock | $916.3M | 11.7 | 1 |
| AMRX | Amneal Pharmaceuticals, Inc. - Class A Common Stock | $5.9B | 47.9 | — |
| ANIP | ANI Pharmaceuticals, Inc. - Common Stock | $1.8B | 19.1 | — |
| ANRO | Alto Neuroscience, Inc. Common Stock | $832.5M | — | — |
| ANTX | AN2 Therapeutics, Inc. - Common Stock | $169.9M | — | — |
| AQST | Aquestive Therapeutics, Inc. - Common Stock | $544.5M | — | — |
| ARTL | Artelo Biosciences, Inc. - Common Stock | $2.5M | — | — |
| ARVN | Arvinas, Inc. - Common Stock | $518.1M | — | — |
| ASBP | Aspire Biopharma Holdings, Inc. - Common Stock | $18.3M | — | — |
| ATAI | AtaiBeckley Inc. - Common Stock | $1.5B | — | — |
| AVIR | Atea Pharmaceuticals, Inc. - common stock | $401.7M | — | — |
| AXSM | Axsome Therapeutics, Inc. - Common Stock | $10.9B | — | — |
| AYTU | Aytu BioPharma, Inc. - Common Stock | $25.4M | — | — |
| AZN | AstraZeneca PLC - American Depositary Shares | $213.8B | 30.6 | 5 |
| BFRI | Biofrontera Inc. - Common Stock | $15.5M | — | — |
| BGM | BGM Group Ltd. - Class A Ordinary Shares | $678.8M | — | — |
| BHC | Bausch Health Companies Inc. Common Stock | $2.9B | 13.6 | — |
| BIOA | BioAge Labs, Inc. - Common Stock | $525.5M | — | — |
| BLTE | Belite Bio, Inc - American Depositary Shares | $5.5B | — | — |
| BMY | Bristol-Myers Squibb Company Common Stock | $130.0B | 21.8 | — |
| BTMD | Biote Corp. - Class A common stock | $84.9M | 5.4 | — |
| CALC | CalciMedica, Inc. - Common Stock | $10.4M | — | — |
| CGC | Canopy Growth Corporation - Common Shares | $574.8M | — | — |
| CGTX | Cognition Therapeutics, Inc. - Common Stock | $94.0M | — | — |
| CING | Cingulate Inc. - Common Stock | $56.0M | — | — |
| CMND | Clearmind Medicine Inc. - Common Shares | $2.7M | — | — |
| CNSP | CNS Pharmaceuticals, Inc. - Common Stock | $7.3M | — | — |
| CNTX | Context Therapeutics Inc. - Common Stock | $41.6M | — | — |
| COCP | Cocrystal Pharma, Inc. - Common Stock | $16.5M | — | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | $1.2B | 15.5 | 1 |
| CORT | Corcept Therapeutics Incorporated - Common Stock | $13.0B | 273.8 | — |
| CPIX | Cumberland Pharmaceuticals Inc. - Common Stock | $115.5M | — | — |
| CRDL | Cardiol Therapeutics Inc. - Class A Common Shares | $131.0M | — | — |
| CRMD | CorMedix Inc. - Common Stock | $557.0M | 3.1 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock | $8.9B | — | — |
| CRON | Cronos Group Inc. - Common Share | $1.4B | 27.8 | — |
| CTNM | Contineum Therapeutics, Inc. - Common stock | $575.6M | — | — |
| CTXR | Citius Pharmaceuticals, Inc. - Common Stock | $16.1M | — | — |
| CURX | Curanex Pharmaceuticals Inc - Common Stock | $9.4M | — | — |
| CVKD | Cadrenal Therapeutics, Inc. - Common Stock | $18.7M | — | — |
| DARE | Dare Bioscience, Inc. - Common Stock | $41.6M | — | — |
| DERM | Journey Medical Corporation - Common Stock | $177.3M | — | — |
| ELAN | Elanco Animal Health Incorporated Common Stock | $12.7B | — | — |
| ELVN | Enliven Therapeutics, Inc. - Common Stock | $4.3B | — | — |
| ENVB | Enveric Biosciences, Inc. - Common Stock | $2.2M | — | — |
| EOLS | Evolus, Inc. - Common Stock | $404.0M | — | — |
| ETON | Eton Pharmaceuticals, Inc. - Common Stock | $1.1B | — | — |
| EWTX | Edgewise Therapeutics, Inc. - Common Stock | $4.8B | — | — |
| EYPT | EyePoint, Inc. - Common Stock | $970.9M | — | — |
| FULC | Fulcrum Therapeutics, Inc. - Common Stock | $288.0M | — | — |
| GELS | Gelteq Limited - Ordinary Shares | $8.6M | — | — |
| GHRS | GH Research PLC - Ordinary Shares | $1.9B | — | — |
| GPCR | Structure Therapeutics Inc. - American Depositary Shares | $3.7B | — | — |
| GRCE | Grace Therapeutics, Inc. - Common Stock | $53.5M | — | — |
| GSK | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | $85.1B | 14.9 | — |
| HCM | HUTCHMED (China) Limited - American Depositary Shares | $18.0B | 5.0 | — |
| HIND | Vyome Holdings, Inc. - Common Stock | $15.5M | — | — |
| HITI | High Tide Inc. - Common Shares | $319.7M | — | — |
| HLN | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $31.4B | 18.9 | — |
| HRMY | Harmony Biosciences Holdings, Inc. - Common Stock | $2.3B | 12.5 | — |
| HROW | Harrow, Inc. - Common Stock | $1.5B | — | — |
| HYPD | Hyperion DeFi, Inc. - Common Stock | $40.0M | — | — |
| IMA | ImageneBio, Inc. - Common Stock | $64.2M | — | — |
| IMCC | IM Cannabis Corp. - Common Shares | $10.6M | — | — |
| INCR | Intercure Ltd. - ordinary shares | $176.9M | — | — |
| INDV | Indivior Pharmaceuticals, Inc. - Common Stock | $4.6B | 12.9 | 1 |
| INM | InMed Pharmaceuticals Inc. - Common Shares | $3.0M | — | — |
| INVA | Innoviva, Inc. - Common Stock | $1.5B | 3.0 | 2 |
| IXHL | Incannex Healthcare Inc. - Common Stock | $37.8M | — | — |
| JAGX | Jaguar Health, Inc. - Common Stock | $1.5M | — | — |
| JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | $15.6B | 530.6 | — |
| JNJ | Johnson & Johnson Common Stock | $605.0B | 28.8 | — |
| JUNS | Jupiter Neurosciences, Inc. - Common Stock | $35.1M | — | — |
| KPRX | Kiora Pharmaceuticals, Inc. - Common Stock | $11.7M | — | — |
| LBRX | LB Pharmaceuticals Inc - Common Stock | $563.2M | — | — |
| LENZ | LENZ Therapeutics, Inc. - Common Stock | $144.5M | — | — |
| LEXX | Lexaria Bioscience Corp. - Common Stock | $15.4M | — | — |
| LGND | Ligand Pharmaceuticals Incorporated - Common Stock | $5.9B | 38.7 | — |
| LLY | Eli Lilly and Company Common Stock | $1.1T | 44.3 | — |
| LPCN | Lipocine Inc. - Common Stock | $17.6M | — | — |
| LQDA | Liquidia Corporation - Common Stock | $8.1B | 362.9 | — |
| LXRX | Lexicon Pharmaceuticals, Inc. - Common Stock | $1.0B | — | — |
| MANE | Veradermics, Incorporated Common Stock | $2.6B | — | — |
| MAZE | Maze Therapeutics, Inc. - Common Stock | $1.4B | — | — |
| MBX | MBX Biosciences, Inc. - Common Stock | $3.2B | — | — |
| MDWD | MediWound Ltd. - Ordinary Shares | $178.7M | — | — |
| MIRA | MIRA Pharmaceuticals, Inc. - Common Stock | $32.2M | — | — |
| MIST | Milestone Pharmaceuticals Inc. - Common Shares | $157.5M | — | — |
| MRK | Merck & Company, Inc. Common Stock (new) | $316.3B | 35.4 | — |
| NKTR | Nektar Therapeutics - Common Stock | $2.6B | — | — |
| NMRA | Neumora Therapeutics, Inc. - Common Stock | $340.9M | — | — |
| NRXP | NRX Pharmaceuticals, Inc. - Common Stock | $108.5M | — | — |
| NTHI | NeOnc Technologies Holdings, Inc. - Common Stock | $139.1M | — | — |
| NTRB | Nutriband Inc. - Common Stock | $55.3M | — | — |
| NUVB | Nuvation Bio Inc. Class A Common Stock | $2.2B | — | — |
| NVO | Novo Nordisk A/S Common Stock | $1.1T | 10.9 | — |
| NVS | Novartis AG Common Stock | $216.0B | 19.7 | — |
| OCS | Oculis Holding AG - Ordinary shares | $707.8M | — | — |
| OCUL | Ocular Therapeutix, Inc. - Common Stock | $2.0B | — | — |
| OGI | Organigram Global Inc. - Common Shares | $311.9M | — | — |
| OGN | Organon & Co. Common Stock | $3.6B | 17.1 | — |
| OMER | Omeros Corporation - Common Stock | $1.2B | 14.4 | — |
| ORMP | Oramed Pharmaceuticals Inc. - Common Stock | $113.4M | 2.6 | — |
| PAHC | Phibro Animal Health Corporation - Class A Common Stock | $1.5B | 22.4 | — |
| PBH | Prestige Consumer Healthcare Inc. Common Stock | $2.7B | 14.5 | — |
| PCRX | Pacira BioSciences, Inc. - Common Stock | $1.1B | 210.7 | — |
| PCSA | Processa Pharmaceuticals, Inc. - Common Stock | $6.5M | — | — |
| PFE | Pfizer, Inc. Common Stock | $145.1B | 19.4 | — |
| PHAT | Phathom Pharmaceuticals, Inc. - Common Stock | $679.2M | — | — |
| PHVS | Pharvaris N.V. - Ordinary Shares | $2.0B | — | — |
| PLRX | Pliant Therapeutics, Inc. - Common Stock | $71.2M | — | — |
| PPBT | Purple Biotech Ltd. - American Depositary Shares | $22.3M | — | — |
| PRFX | PRF Technologies Ltd. - Ordinary Shares | $2.5M | — | — |
| PRGO | Perrigo Company plc Ordinary Shares | $1.7B | — | — |
| PULM | Pulmatrix, Inc. - Common Stock | $8.1M | — | — |
| PYPD | PolyPid Ltd. - Ordinary Shares | $91.0M | — | — |
| QCLS | Q/C Technologies, Inc. - Common Stock | $16.6M | — | — |
| QNTM | Quantum Biopharma Ltd. - Class B Subordinate Voting Shares | $40.4M | — | — |
| RANI | Rani Therapeutics Holdings, Inc. - Class A Common Stock | $133.7M | — | — |
| RAPP | Rapport Therapeutics, Inc. - Common Stock | $2.2B | — | — |
| RDHL | Redhill Biopharma Ltd. - American Depositary Shares | $4.7M | — | — |
| RDY | Dr. Reddy's Laboratories Ltd Common Stock | $1.0T | 18.3 | — |
| RFL | Rafael Holdings, Inc. Class B Common Stock | $63.5M | — | — |
| RGC | Regencell Bioscience Holdings Limited - Ordinary Shares | $10.4B | — | — |
| RLMD | Relmada Therapeutics, Inc. - Common Stock | $484.3M | — | — |
| RPRX | Royalty Pharma plc - Class A Ordinary Shares | $33.3B | 40.9 | — |
| SCLX | Scilex Holding Company - Common Stock | $51.0M | — | — |
| SCYX | SCYNEXIS, Inc. - Common Stock | $58.8M | — | — |
| SEPN | Septerna, Inc. - Common Stock | $2.1B | — | — |
| SIGA | SIGA Technologies Inc. - Common Stock | $226.3M | 11.2 | — |
| SLGL | Sol-Gel Technologies Ltd. - Ordinary Shares | $241.4M | — | — |
| SNDL | SNDL Inc. - Common Shares | $298.0M | — | — |
| SNES | SenesTech, Inc. - Common Stock | $6.7M | — | — |
| SNOA | Sonoma Pharmaceuticals, Inc. - Common Stock | $6.2M | — | — |
| SNY | Sanofi - American Depositary Shares | $100.2B | 7.2 | 5 |
| SPRC | SciSparc Ltd. - Ordinary Shares | $4.5M | — | — |
| SUPN | Supernus Pharmaceuticals, Inc. - Common Stock | $2.8B | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. - Common Stock | $185.6M | — | — |
| SXTP | 60 Degrees Pharmaceuticals, Inc. - Common Stock | $3.7M | — | — |
| TAK | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | $9.0T | 79.4 | — |
| TARS | Tarsus Pharmaceuticals, Inc. - Common Stock | $2.6B | — | — |
| TBPH | Theravance Biopharma, Inc. - Ordinary Shares | $867.1M | 7.6 | — |
| TELO | Telomir Pharmaceuticals, Inc. - Common Stock | $45.7M | — | — |
| TEVA | Teva Pharmaceutical Industries Limited American Depositary Shares | $108.9B | 25.4 | — |
| TLPH | Talphera, Inc. - Common Stock | $72.7M | — | — |
| TLRY | Tilray Brands, Inc. - Common Stock | $1.0B | — | — |
| TRAW | Traws Pharma, Inc. - Common Stock | $24.2M | 2.6 | — |
| TRVI | Trevi Therapeutics, Inc. - Common Stock | $2.6B | — | — |
| TTRX | Turn Therapeutics Inc. - Common Stock | — | — | — |
| TVRD | Tvardi Therapeutics, Inc. - Common Stock | $37.5M | — | — |
| TXMD | TherapeuticsMD, Inc. - Common Stock | $18.9M | 62.5 | — |
| UPC | Universe Pharmaceuticals Inc - Class A Ordinary Shares | $2.1M | 2.0 | — |
| VERU | Veru Inc. - Common Stock | $37.7M | — | — |
| VRCA | Verrica Pharmaceuticals Inc. - Common Stock | $86.8M | — | — |
| VTRS | Viatris Inc. - Common Stock | $20.6B | — | — |
| WVE | Wave Life Sciences Ltd. - Ordinary Shares | $1.1B | — | — |
| XERS | Xeris Biopharma Holdings, Inc. - Common Stock | $1.4B | 117.7 | — |
| XRTX | XORTX Therapeutics Inc. - Common Stock | $5.5M | — | — |
| ZTS | Zoetis Inc. Class A Common Stock | $31.9B | 12.1 | — |
| ZVRA | Zevra Therapeutics, Inc. - Common Stock | $683.4M | 11.7 | 1 |
| ZYBT | Zhengye Biotechnology Holding Limited - Ordinary Shares | $79.6M | 14.2 | — |
Ninguna acción coincide con sus filtros
Intente ajustar sus criterios de búsqueda
Cargando más acciones...